Andrew Rock

Mr. Rock earned a reputation as a successful serial entrepreneur in the global medical technology industry. He is co-founder of K2M Group, a medical device developer based in Leesburg, Va., which became listed as a publicly-traded company on NASDAQ on May 5, 2014. While at K2M, Mr. Rock developed over 17 utility and method patents for the treatment of complex spine pathologies including scoliosis, tumor, and trauma, as well as for minimally invasive implants. Before his involvement in K2M, Mr. Rock was a member of the executive management team at American Osteomedix, where he co-developed a minimally invasive approach to access and treat osteoporotic compression fractures and tumors in the thoracic spine. From 1993 to 2003, he was Chairman and CEO of Rock Surgical Associates, Inc., a distributor of Orthopedic and Neurosurgical Products in the Mid-Atlantic region. Currently, Mr. Rock is the founder and managing partner of Neuro Spine Ventures LLC, an 82-member global angel investor group. Mr. Rock is also Co-Founder and Executive Director of DP Enterprises Group Inc., which provides product development and global marketing services for med-tech companies. Mr. Rock also serves on the Board of Directors for several corporations, including Quadrant Biosciences, Inc. which focuses on brain health and epigenetics diagnostics; Minneapolis-based St Teresa Medical Inc., a developer of nanotechnology-based hemostatic and dural sealants; Connecticut based Woven Orthopedics, LLC which specializes in fixation and osteoporotic and osteopenic. He is on the board of advisors for Indianapolis-based Recovery Force, LLC, and a pioneer in wearable technology for the medical, sports, and defense industry sectors Mr. Rock graduated from Linsly and West Virginia University.